Search

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which emerged as a novel pathogen in 2019. The virus is responsible for a severe acute respiratory syndrome outbreak, affecting the respiratory system of infected individuals. COVID-19 is a super amplifier of basic diseases, and the disease with basic diseases is often more serious. Controlling the spread of the COVID-19 pandemic relies heavily on the timely and accurate detection of the virus. To resolve the problem, a polyaniline functionalized NiFeP nanosheet array-based electrochemical immunosensor using Au/Cu2O nanocubes as a signal amplifier is fabricated for the detection of SARS-CoV-2 nucleocapsid protein (SARS-CoV-2 NP). Polyaniline (PANI) functionalized NiFeP nanosheet arrays are synthesized as an ideal sensing platform for the first time. PANI is coated on the surface of NiFeP by electropolymerization to enhance biocompatibility, beneficial for the efficient loading of the capture antibody (Ab1). Significantly, Au/Cu2O nanocubes possess excellent peroxidase-like activity and exhibit outstanding catalytic activity for the reduction of H2O2. Therefore, Au/Cu2O nanocubes combine with a labeled antibody (Ab2) through the Au–N bond to form labeled probes, which can effectively amplify current signals. Under optimal conditions, the immunosensor for the detection of SARS-CoV-2 NP shows a wide linear range of 10 fg mL−1–20 ng mL−1 and a low detection limit of 1.12 fg mL−1 (S/N = 3). It also exhibits desirable selectivity, repeatability, and stability. Meanwhile, the excellent analytical performance in human serum samples confirms the practicality of the PANI functionalized NiFeP nanosheet array-based immunosensor. The electrochemical immunosensor based on the Au/Cu2O nanocubes as a signal amplifier demonstrates great potential for application in the personalized point-of-care (POC) clinical diagnosis. [ABSTRACT FROM AUTHOR]

This work proposes a new circularly polarized (CP) 4 × 4 magneto-electric (ME) dipole antenna array using metallic walls for 28 GHz band applications. The ME dipole element is surrounded by eight metallic walls and is excited fed by microstrip line. By introducing metallic walls, the 3-dB axial ratio (AR) bandwidth of the element is increased from 23% to 36.5%. The 4 × 4 array is fed by a simple 1-to-16 microstrip power divider. In contrast to the conventional substrate integrated waveguide (SIW) power divider using two layers, the proposed microstrip divider only needs one substrate layer. The experimental 3-dB AR bandwidth of the array achieves 30.1%, ranging from 22.5 to 30.5 GHz, which falls inside the −10 dB impendence bandwidth. The measured maximum gain is 19.2 dBic. [ABSTRACT FROM AUTHOR]

Detection of tumor biomarkers is of great significance for early diagnosis of cancer. Herein, we fabricated a novel lab-on-a chip surface-enhanced Raman scattering (SERS) (LoC-SERS) biosensing platform for highly sensitive and specific detection of thrombin and platelet-derived growth factor-B (PDGF-B) using aptamer recognition technology. This strategy relies on the specific aptamer recognition between SERS probes (Ag–Au core–shell nanorods (Ag–AuNRs) modified with Raman reporter molecules and detection aptamer) and SERS capture substrate (Au nanoflower (AuNF) substrates modified with capture aptamer), which significantly amplify the plasmonic coupling effect that allows the ultrasensitive and high specificity SERS detection. The limits of detection (LODs) are as low as 3.62 fM for thrombin and 2.86 fM for PDGF-B. Such LoC-SERS platform is further employed to simultaneously detect two types of gastric carcinoma-related with high sensitivity and specificity, which meanwhile exhibit robust capacity of resisting disturbance in practical samples. The results revealed that the present LoC-SERS platform displayed excellent analytical performance, including superior reproducibility, specificity, and sensitivity. Satisfactory results were obtained in real sample analysis with the LoC-SERS platform. [ABSTRACT FROM AUTHOR]

Dual-labeled fluorescence hybridization probe-based multiplex quantitative real-time polymerase chain reaction (qPCR) assay was used for the detection of Clostridium perfringens toxin genes alpha (cpa), beta (cpb), iota (ia), epsilon (etx), beta2 (cpb2) and enterotoxin (cpe) directly from the feces of cattle. Fecal samples from 261 lactating cattle, belonging to three dairy herds in Ningxia (China), were examined using the developed assays. The duplex qPCR assay revealed that cpa, etx, cpb2 and cpe toxin genes were detected in 176 (100%), 15 (8.5%), 142 (80.7%) and 4 (2.3%) of 176 PCR positive samples, respectively. The findings of this study revealed that C. perfringens beta2-toxin-producing strains were widely prevalent in lactating cows in Ningxia, possibly playing an important role in C. perfringens-associated diarrheal disease.

A novel surface-enhanced Raman scattering and lateral flow assay (SERS–LFA) biosensor with multiple channels based on an aptamer has been proposed in this work. The developed biosensor was designed for the rapid, convenient, sensitive and specific detection of vascular endothelial growth factor (VEGF) and osteopontin (OPN) in several samples simultaneously. During the assay, VEGF and OPN were recognized by detection aptamers immobilized on cuprous oxide nanocubes (Cu2O NCs) and captured by capture aptamers to form a sandwich structure on the test lines. In this way, generous numbers of "hot spots" formed by the aggregation of Cu2O NCs remarkably enhanced the SERS signals of Raman reporters (NBA and 4-ATP). The detection limits were as low as 0.78 pg mL−1 for the VEGF and 0.86 pg mL−1 for OPN in the human serum within 15 min, respectively. Additionally, the biosensor possesses favorable specificity, reproducibility, uniformity and stability. In the clinical analysis of serum specimens, patients with cervical cancer can be differentiated from healthy volunteers. Consequently, the presented aptamer-based SERS–LFA biosensor with multiple channels provides a powerful tool for the early diagnosis of cervical cancer. [ABSTRACT FROM AUTHOR]

In this study, we apply catalytic hairpin assembly (CHA) as the signal amplification strategy for the quantification of carcinoembryonic antigen (CEA) and cytokeratin fragment antigen 21-1 (CYFRA21-1) with a surface-enhanced Raman scattering (SERS) microfluidic chip (LoC-SERS) as the carrier. Herein, antibody–DNA conjugates are designed to assist the application of CHA amplification in protein detection. In the presence of protein biomarkers, antibody–DNA conjugates can specifically bind to the target proteins, forming the antigen@antibody–DNA conjugates. The terminal free part of the DNA on the conjugates can trigger the CHA events to connect SERS nanotags to capture nanoprobes. Then, micro-magnet can gather the CHA products in a rectangular chamber, resulting in the aggregation of SERS nanotags, which can ultimately generate abundant "hot spots" for SERS signal enhancement. Using this strategy, CEA and CYFRA21-1 can be successfully determined with a limit of detection (LOD) as low as pg mL−1, much lower than recently reported methods. Meanwhile, a non-small cell lung cancer (NSCLC)-xenografted mouse model was established, and SERS was applied to analyze the expression level of CEA and CYFRA21-1 in tumorigenesis and development. The comparison between SERS results and those of the ELISA method demonstrated a high degree of consistency, suggesting that the proposed CHA-assisted LoC-SERS device has satisfying accuracy. Thus, introducing the CHA strategy via the design of antibody–DNA conjugates opens new gates to ultra-sensitive and specific SERS detection of protein biomarkers. [ABSTRACT FROM AUTHOR]

In this work, a microfluidic chip using Au@SiO2 array–based highly active SERS substrates was developed for quantitative detection of squamous cell carcinoma antigen (SCCA) and carcinoembryonic antigen (CEA) associated with cervical cancer. The chip consisted of six functional units with pump-free design, enabling parallel detection of multiple samples in an automatic manner without external pumps and improving the portability. Ag nanocubes (AgNCs) were labeled with Raman reporters and coupled with antibodies (labeling) to prepare SERS tags, while the Au nanoparticle–modified SiO2 microsphere (Au@SiO2) array was conjugated with antibodies (coating) to generate the highly SERS-active capturing substrate. In the presence of target biomarkers, they were captured by SERS tags and capturing substrate, resulting in the formation of "sandwich" structures which were trapped in the detection chamber. As the immune reaction proceeded, a large number of "hot spots" were generated by the proximity of the Au@SiO2 array substrate and AgNCs, greatly amplifying SERS signals. With this chip, the limits of detection of the SCCA and CEA levels in human serum were estimated to be as low as 0.45 pg mL−1 and 0.36 pg mL−1, respectively. Furthermore, the good selectivity and reproducibility of this chip were confirmed. Finally, clinical serum samples were analyzed by this chip, and the outcomes were consistent with those of enzyme-linked immunosorbent assay (ELISA). Thus, the proposed microfluidic chip can be potentially applied for the clinical diagnosis of cervical cancer. [ABSTRACT FROM AUTHOR]

In this communication, a reconfigurable 2-bit leaky-wave antenna (LWA) is proposed for low-cost fixed-frequency beam-steering applications. The proposed antenna consists of a microstrip transmission line loaded with several branches, a series of 2-bit phase shifters, and a $1\times 8$ patch array. Each phase shifter is built by selecting the feed directions on the branch and introducing slot perturbation on the patch, thus no phase delay line is used. Only three p-i-n diodes are needed to control the 0°, 90°, 180°, and 270° states of the element. The reference phase $\varphi _{0}$ , namely the phase of the first element, is utilized to enhance the peak gain of the array. The stopband effect of broadside beam is eliminated due to the perturbation on the patches. The prototype is tested at 3.6 GHz. The measured peak gain is 13.54 dBi, and the main beam can steer from $- \mathrm{48}^{\circ }$ to $+ \mathrm{46}^{\circ }$. [ABSTRACT FROM AUTHOR]